Group plots new biotech building in MD

Alexandria Real Estate Equities has laid plans to build a four-story, 100,000-square-foot biotech lab on Maryland's I-270 corridor--an area that's already thick with developers. The group refused to say how much the project will costs but aims to have the building completed by the end of 2012. Report

Suggested Articles

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.

Johns Hopkins researchers developed a biodegradable polymer to transport large therapies into cells—including genes and even CRISPR.

UCB’s bispecific antibody recently beat Johnson & Johnson’s Stelara at clearing psoriasis symptoms, and now it has bested AbbVie’s Humira, too.